| Mrs Janice Osborne Dowdy, MS, CCC-SLP, CBIS | |
|
2150 Carter Ave, Ashland, KY 41101-7734 | |
| (606) 324-1609 | |
| Not Available |
| Full Name | Mrs Janice Osborne Dowdy |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2150 Carter Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700243474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3467 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Janice Osborne Dowdy, MS, CCC-SLP, CBIS 2150 Carter Ave, Ashland, KY 41101-7734 Ph: (606) 324-1609 | Mrs Janice Osborne Dowdy, MS, CCC-SLP, CBIS 2150 Carter Ave, Ashland, KY 41101-7734 Ph: (606) 324-1609 |
News Archive
Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.
Menicon Co., Ltd., Japan's leading contact lens manufacturer, recently donated 3 million yen plus staff volunteer time to the revitalization of three soccer pitches in the Tohoku region, as part of an ongoing effort to assist communities stricken by the earthquake, tsunami and nuclear disasters of March 11, 2011.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Company has achieved delivery of novel small interfering RNA conjugates to the central nervous system and is planning to advance a pipeline of investigational RNAi therapeutics into clinical development.
A preliminary report suggests that cell-free fetal messenger RNA (ribonucleic acid) can be extracted from amniotic fluid (fluid around the fetus), and then be analyzed to study gene expression changes that may reflect the well-being of the fetus, according to a paper in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.
› Verified 8 days ago
Mrs. Terri Diane Morgan, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2510 W Rockhouse Rd, Ashland, KY 41102 Phone: 606-571-9064 Fax: 606-324-7238 | |
Jennifer Chapman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12862 State Route 180, Ashland, KY 41102 Phone: 606-928-5805 | |
Amanda Rose Maxim, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 Bob Mccullough Dr, Ashland, KY 41102 Phone: 606-928-4141 | |
Kelley Lynne Gillum, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 | |
Mrs. Ashlee Nikole Dudley, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 12862 Ky-180, Ashland, KY 41102 Phone: 606-928-5805 | |
Pathways, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1212 Bath Ave, Ashland, KY 41101 Phone: 606-329-8588 Fax: 606-329-8195 | |
Lonnie Carpenter, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2150 Carter Ave, Ashland, KY 41101 Phone: 606-325-1338 |